Article Text
Abstract
Radiotherapy is the mainstay of treatment after surgery for high-grade gliomas and is usually well tolerated. Radiation toxicity in the brain is usually classified according to the timing of side effects in relation to treatment, as either acute (during radiotherapy), early delayed (within 12 weeks of radiotherapy) or late delayed (months to years after radiotherapy). We report two cases of young women who developed severe acute demyelination within 4 months of radiotherapy for glioma, one of whom had a previous history of transverse myelitis. Both improved with corticosteroids and remain in tumour remission. These cases emphasise the importance of careful discussion with patients before starting radiotherapy if there is a previous history of central nervous system demyelination or multiple white matter lesions on MRI.
- MULTIPLE SCLEROSIS
- brain tumour
- acute demyelination
- glioma
- RADIOTHERAPY
Statistics from Altmetric.com
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
Read the full text or download the PDF:
Other content recommended for you
- ARID4B is a good biomarker to predict tumour behaviour and decide WHO grades in gliomas and meningiomas
- WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma
- Clinical importance of molecular markers of adult diffuse glioma
- A simple algorithmic approach using histology and immunohistochemistry for the current classification of adult diffuse glioma in a resource - limited set - up
- Phosphorylated Hsp27 is mutually exclusive with ATRX loss and the IDH1R132 H mutation and may predict better prognosis among glioblastomas without the IDH1 mutation and ATRX loss
- Isocitrate dehydrogenase mutations in diffuse gliomas: clinical and aetiological implications
- A case of oligodendroglioma and multiple sclerosis: Occam ’s razor or Hickam ’s dictum
- Potential biomarkers and challenges in glioma diagnosis, therapy and prognosis
- Neuro - oncology
- Brain tumour mimics and chameleons